DK0719859T3 - Anti-alfa V-integrin monoklonalt antistof - Google Patents
Anti-alfa V-integrin monoklonalt antistofInfo
- Publication number
- DK0719859T3 DK0719859T3 DK95119233T DK95119233T DK0719859T3 DK 0719859 T3 DK0719859 T3 DK 0719859T3 DK 95119233 T DK95119233 T DK 95119233T DK 95119233 T DK95119233 T DK 95119233T DK 0719859 T3 DK0719859 T3 DK 0719859T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- monoclonal antibody
- integrin monoclonal
- integrin
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94120165 | 1994-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0719859T3 true DK0719859T3 (da) | 2003-10-20 |
Family
ID=8216547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95119233T DK0719859T3 (da) | 1994-12-20 | 1995-12-06 | Anti-alfa V-integrin monoklonalt antistof |
Country Status (26)
Country | Link |
---|---|
US (1) | US5985278A (es) |
EP (1) | EP0719859B1 (es) |
JP (1) | JP3898245B2 (es) |
KR (1) | KR100450368B1 (es) |
CN (1) | CN1117763C (es) |
AR (1) | AR001778A1 (es) |
AT (1) | ATE244306T1 (es) |
AU (1) | AU710234B2 (es) |
BR (1) | BR9505980B1 (es) |
CA (1) | CA2165573C (es) |
CO (1) | CO4480042A1 (es) |
CZ (1) | CZ290477B6 (es) |
DE (1) | DE69531187T2 (es) |
DK (1) | DK0719859T3 (es) |
ES (1) | ES2202336T3 (es) |
FI (1) | FI118536B (es) |
HU (1) | HU221061B1 (es) |
NO (1) | NO321186B1 (es) |
PL (1) | PL182961B1 (es) |
PT (1) | PT719859E (es) |
RU (1) | RU2205223C2 (es) |
SI (1) | SI0719859T1 (es) |
SK (1) | SK284932B6 (es) |
TR (1) | TR199501614A2 (es) |
UA (1) | UA40621C2 (es) |
ZA (1) | ZA9510806B (es) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998009651A1 (fr) * | 1996-09-03 | 1998-03-12 | Chugai Seiyaku Kabushiki Kaisha | COMPLEXES D'ANTICORPS ANTI-INTEGRINE α3 |
DE69739295D1 (de) * | 1996-12-09 | 2009-04-23 | Merck Patent Gmbh | Löslicher, rekombinanter alphaV beta3 Adhäsionsrezeptor |
DE69828614T2 (de) * | 1997-08-08 | 2006-02-09 | The Regents Of The University Of California, Oakland | Behandlung von Nierenfibrose durch Antikörper gegen integrin alpha-v-beta 6 |
ATE322508T1 (de) * | 1998-01-23 | 2006-04-15 | Merck Patent Gmbh | Verwendung des antikörpers 271.14d9.f8 (dsm acc2331) um die bindung zwischen alphavbeta6- integrin und fibronectin in vitro zu hemmen |
US6160099A (en) * | 1998-11-24 | 2000-12-12 | Jonak; Zdenka Ludmila | Anti-human αv β3 and αv β5 antibodies |
US6521593B1 (en) * | 1999-02-01 | 2003-02-18 | Childrens Hospital Los Angeles | Methods for inhibiting brain tumor growth |
US7153944B2 (en) * | 2000-07-31 | 2006-12-26 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
US7064180B2 (en) | 2000-07-31 | 2006-06-20 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
US7323552B2 (en) * | 2000-07-31 | 2008-01-29 | The General Hospital Corporation | Variant integrin polypeptides and uses thereof |
US7288390B2 (en) | 2000-08-07 | 2007-10-30 | Centocor, Inc. | Anti-dual integrin antibodies, compositions, methods and uses |
US7163681B2 (en) | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
CA2439852A1 (en) * | 2001-03-02 | 2002-09-12 | Christine Dingivan | Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
KR100861466B1 (ko) | 2001-04-24 | 2008-10-02 | 메르크 파텐트 게엠베하 | 항혈관형성제 및 TNFα를 이용한 병용 요법 |
CA2453403C (en) | 2001-07-09 | 2013-10-08 | Elan Pharmaceuticals, Inc. | Methods of inhibiting amyloid toxicity |
US7829087B2 (en) * | 2001-07-09 | 2010-11-09 | Elan Pharmaceuticals, Inc. | Methods of treating cognitive impairment |
AU2003217930A1 (en) * | 2002-03-04 | 2003-09-22 | Medimmune, Llc | The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
EP1487489A4 (en) * | 2002-03-04 | 2008-10-01 | Medimmune Inc | METHODS FOR PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN AVB3 ANTAGONIST ASSOCIATED WITH HMG-COA REDUCTASE INHIBITOR OR BISPHOSPHONATE |
WO2003100033A2 (en) | 2002-03-13 | 2003-12-04 | Biogen Idec Ma Inc. | ANTI-αvβ6 ANTIBODIES |
UA90242C2 (ru) * | 2002-03-13 | 2010-04-26 | Байоджен Айдек Ма Инк. | МОНОКЛОНАЛЬНОЕ АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С αVβ6 |
WO2003087340A2 (en) * | 2002-04-12 | 2003-10-23 | Raven Biotechnologies, Inc. | Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
WO2003086458A1 (en) | 2002-04-12 | 2003-10-23 | Medimmune, Inc. | Recombinant anti-interleukin-9 antibodies |
JP2006516635A (ja) * | 2003-01-30 | 2006-07-06 | メディミューン,インコーポレーテッド | インテグリンαvβ3アンタゴニストの使用 |
KR101224235B1 (ko) | 2003-04-11 | 2013-01-25 | 메디뮨 엘엘씨 | 재조합 il9 항체 및 그의 용도 |
US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
AU2005299355A1 (en) | 2004-10-27 | 2006-05-04 | Medimmune, Llc | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
CN102875681A (zh) | 2005-07-08 | 2013-01-16 | 拜奥根Idec马萨诸塞公司 | 抗-αvβ6抗体及其用途 |
WO2008060645A2 (en) * | 2006-03-21 | 2008-05-22 | Genentech, Inc. | Combinatorial therapy involving alpha5beta1 antagonists |
BRPI0714381A2 (pt) | 2006-07-10 | 2013-03-05 | Biogen Idec Inc | composiÇÕes e mÉtodos para inibir crescimento de cÂnceres deficientes em smad4 |
CA2657581A1 (en) | 2006-07-11 | 2008-01-17 | Roy C. Levitt | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
JP2010500360A (ja) | 2006-08-10 | 2010-01-07 | アルボア コーポレーション | 炎症性サイトカイン阻害剤による下気道炎症疾患の局所療法 |
WO2008141274A1 (en) * | 2007-05-11 | 2008-11-20 | Centocor, Inc. | Anti-alpha v immunoliposome composition, methods and uses |
US20090196913A1 (en) * | 2007-05-11 | 2009-08-06 | Ken Shi Kun Huang | Anti-Alpha-V Immunoliposome Composition, Methods, and Uses |
SI2167128T1 (sl) * | 2007-07-17 | 2013-01-31 | Merck Patent Gmbh | Z genetskim inĺ˝enirstvom pridobljena hibridna protitelesa proti alfa v- integrinu |
AR066170A1 (es) * | 2007-09-26 | 2009-07-29 | Genentech Inc | Anti integrina alfa 5 beta 1 |
JP5680547B2 (ja) | 2008-12-23 | 2015-03-04 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 抗血管形成活性を有するインヒビターのためのバイオマーカー |
WO2010111254A1 (en) | 2009-03-25 | 2010-09-30 | Genentech, Inc. | Novel anti-alpha5beta1 antibodies and uses thereof |
EP2498821A1 (en) | 2009-11-13 | 2012-09-19 | Merck Patent GmbH | Anti integrin antibodies linked to nanoparticles loaded with chemotherapeutic agents |
AU2011217848B8 (en) * | 2010-02-18 | 2015-09-24 | The Regents Of The University Of California | Integrin aVB8 neutralizing antibody |
WO2012027745A1 (en) * | 2010-08-27 | 2012-03-01 | University Of Miami | Treatment of renal diseases |
KR101972533B1 (ko) | 2011-02-11 | 2019-08-26 | 메르크 파텐트 게엠베하 | 전립선암 치료용 항-알파-v 인테그린 항체 |
CN103826661B (zh) | 2011-04-21 | 2019-03-05 | 西雅图基因公司 | 新的结合剂-药物缀合物(adc)及其用途 |
AU2012296362B2 (en) * | 2011-08-17 | 2017-06-29 | The Regents Of The University Of California | Antibodies that bind integrin alpha-v beta-8 |
WO2014144466A1 (en) | 2013-03-15 | 2014-09-18 | Biogen Idec Ma Inc. | Anti-alpha v beta 6 antibodies and uses thereof |
US10035860B2 (en) | 2013-03-15 | 2018-07-31 | Biogen Ma Inc. | Anti-alpha V beta 6 antibodies and uses thereof |
BR112016014830A2 (pt) | 2013-12-23 | 2017-09-19 | Bayer Pharma AG | Conjugados de fármaco de anticorpo (adcs) com inibidores de ksp |
US10435472B2 (en) | 2014-09-17 | 2019-10-08 | Merck Patent Gmbh | Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases |
CN107073111A (zh) | 2014-09-17 | 2017-08-18 | 默克专利股份公司 | 治疗实体癌和/或其转移的方法、其药物以及预测治疗实体癌和/或其转移的临床结果的方法 |
CN114917361A (zh) | 2015-06-22 | 2022-08-19 | 拜耳医药股份有限公司 | 具有酶可裂解基团的抗体药物缀合物(adc)和抗体前药缀合物(apdc) |
MX2017017138A (es) | 2015-06-23 | 2018-04-30 | Bayer Pharma AG | Conjugados homogeneos especificos de sitio con inhibidores de ksp. |
WO2017060322A2 (en) | 2015-10-10 | 2017-04-13 | Bayer Pharma Aktiengesellschaft | Ptefb-inhibitor-adc |
JP7034914B2 (ja) | 2015-11-23 | 2022-03-14 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 線維症および/または線維性疾患の治療のための抗α-vインテグリン抗体 |
BR112018069483A2 (pt) | 2016-03-24 | 2019-07-30 | Bayer Pharma AG | pró-fármacos de medicamentos citotóxicos contendo grupos enzimaticamente cliváveis. |
EP3919518A1 (en) | 2016-06-15 | 2021-12-08 | Bayer Pharma Aktiengesellschaft | Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies |
WO2018046610A1 (en) | 2016-09-08 | 2018-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating nephrotic syndrome |
EP3558386A1 (de) | 2016-12-21 | 2019-10-30 | Bayer Aktiengesellschaft | Prodrugs von cytotoxischen wirkstoffen mit enzymatisch spaltbaren gruppen |
EP3558387B1 (de) | 2016-12-21 | 2021-10-20 | Bayer Pharma Aktiengesellschaft | Spezifische antikörper-wirkstoff-konjugate (adcs) mit ksp-inhibitoren |
EP3558388A1 (de) | 2016-12-21 | 2019-10-30 | Bayer Pharma Aktiengesellschaft | Binder-wirkstoff-konjugate (adcs) mit enzymatisch spaltbaren gruppen |
KR101961715B1 (ko) | 2018-07-18 | 2019-03-25 | (주) 삼진정밀 | 고효율 수처리장치 |
US20200121788A1 (en) | 2018-10-19 | 2020-04-23 | Merck Patent Gmbh | Abituzumab for the treatment of colorectal cancer |
KR101999620B1 (ko) | 2019-03-26 | 2019-07-12 | 조용진 | 부상슬러지 및 침전슬러지의 동시처리장치 |
WO2020210358A1 (en) * | 2019-04-08 | 2020-10-15 | Biogen Ma Inc. | Anti-integrin antibodies and uses thereof |
CN117143241B (zh) * | 2023-10-26 | 2024-02-23 | 迈威(上海)生物科技股份有限公司 | 与人整合素蛋白itgav/itgb8特异性结合的单克隆抗体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3353209B2 (ja) * | 1992-04-03 | 2002-12-03 | ジェネンテク,インコーポレイテッド | αvβ3インテグリンに対する抗体 |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
-
1995
- 1995-12-06 PT PT95119233T patent/PT719859E/pt unknown
- 1995-12-06 EP EP95119233A patent/EP0719859B1/en not_active Expired - Lifetime
- 1995-12-06 AT AT95119233T patent/ATE244306T1/de active
- 1995-12-06 DE DE69531187T patent/DE69531187T2/de not_active Expired - Lifetime
- 1995-12-06 ES ES95119233T patent/ES2202336T3/es not_active Expired - Lifetime
- 1995-12-06 DK DK95119233T patent/DK0719859T3/da active
- 1995-12-06 SI SI9530683T patent/SI0719859T1/xx unknown
- 1995-12-13 AU AU40421/95A patent/AU710234B2/en not_active Ceased
- 1995-12-13 CZ CZ19953288A patent/CZ290477B6/cs not_active IP Right Cessation
- 1995-12-18 CA CA2165573A patent/CA2165573C/en not_active Expired - Fee Related
- 1995-12-18 JP JP32887795A patent/JP3898245B2/ja not_active Expired - Fee Related
- 1995-12-19 UA UA95125376A patent/UA40621C2/uk unknown
- 1995-12-19 ZA ZA9510806A patent/ZA9510806B/xx unknown
- 1995-12-19 PL PL95311926A patent/PL182961B1/pl unknown
- 1995-12-19 SK SK1592-95A patent/SK284932B6/sk not_active IP Right Cessation
- 1995-12-19 FI FI956112A patent/FI118536B/fi not_active IP Right Cessation
- 1995-12-19 NO NO19955167A patent/NO321186B1/no not_active IP Right Cessation
- 1995-12-19 RU RU95121105/13A patent/RU2205223C2/ru not_active IP Right Cessation
- 1995-12-19 HU HU9503638A patent/HU221061B1/hu not_active IP Right Cessation
- 1995-12-19 CN CN95120901A patent/CN1117763C/zh not_active Expired - Fee Related
- 1995-12-19 US US08/574,699 patent/US5985278A/en not_active Expired - Lifetime
- 1995-12-20 AR AR33473095A patent/AR001778A1/es active IP Right Grant
- 1995-12-20 BR BRPI9505980-6A patent/BR9505980B1/pt not_active IP Right Cessation
- 1995-12-20 TR TR95/01614A patent/TR199501614A2/xx unknown
- 1995-12-20 KR KR1019950052440A patent/KR100450368B1/ko not_active IP Right Cessation
- 1995-12-20 CO CO95060553A patent/CO4480042A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0719859T3 (da) | Anti-alfa V-integrin monoklonalt antistof | |
DK1516629T3 (da) | Humaniseret anti-CD-11a antibodies | |
DE69920897D1 (de) | Monoklonale antikörper mit verringerter immunisierungsfähigkeit | |
DK145493D0 (da) | Antistof | |
CY2005008I1 (el) | Αντισωματα αντι - vegf | |
DE69232604T2 (de) | Antikörperkonstrukte | |
DK0837927T3 (da) | Anti-CD80-antistoffer | |
IL147517A0 (en) | Monoclonal antibodies and immunoassay utilizing the same | |
LV11630A (lv) | T sunu antigena receptora V apgabala pilna garuma olbaltumvielas | |
DE69828154D1 (de) | Anti-alphavbeta3 humanizierte monoklonale antikörper | |
DE69738312D1 (de) | Hepatitis b monoklonale antikörper | |
NO981272D0 (no) | Humanisert anti-human-Fas-antistoff | |
NO972522D0 (no) | Monoklonale antistoffer med immunoundertrykkende aktivitet | |
EP0759943A4 (en) | MONOCLONAL ANTIBODIES SPECIFIC TO AN ENDOGLYX-1 ANTIGEN OF VASCULAR ENDOTHELIAL CELLS, THE ANTIGEN ITSELF AND USES THEREOF | |
GB9718911D0 (en) | Monoclonal antibodies | |
DE69427850D1 (de) | Monoklonaler antikörper gegen mucoglykoprotein | |
NO985281D0 (no) | Monoklonalt antihumant MP52-antistoff | |
DE69324928D1 (de) | Monoklonaler antikörper | |
BR1100555B1 (pt) | anticorpos monoclonais humanizados. | |
BR1100504A (pt) | anticorpos anti-ige. | |
FI963901A0 (fi) | Tie-reseptoria tunnistavat monoklonaaliset vasta-aineet ja niiden käyttö | |
DK0919617T3 (da) | Monoklonale antistoffer mod humant MP52 |